GrantExec

Grants for Public and State controlled institutions of higher education - Health

Explore 196 grant opportunities

Medical Student Education
$3,666,666
Department of Health and Human Services Health Resources and Services Administration
Federal

Application Deadline

Jul 22, 2024

Date Added

May 16, 2024

The purpose of the Medical Student Education (MSE) Program is to provide support to public medical schools in the top quintile of states with a projected primary care physician shortage to expand or support education for medical students preparing to become physicians. The program is designed to prepare and encourage medical students in these schools to choose residencies and careers in primary care and serve tribal, rural, and/or medically underserved communities in those states after they complete their residency.

Health
Public and State controlled institutions of higher education
Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
Contact for amount
US Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Dec 5, 2024

Date Added

May 15, 2024

This initiative will support multi-level and/or multi-domain intervention research to reduce disparities in liver diseases and liver cancer among populations who experience health disparities in the United States (US).

Education
Public and State controlled institutions of higher education
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
$375,000
US Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Jan 8, 2025

Date Added

May 9, 2024

This funding opportunity supports small-scale research projects at undergraduate-focused institutions to enhance research capabilities and engage students in biomedical research.

Education
Public and State controlled institutions of higher education
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
$375,000
U.S. Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Not specified

Date Added

May 9, 2024

This grant provides funding to undergraduate-focused institutions to support small-scale clinical trials that engage students in meaningful biomedical research experiences.

Education
Public and State controlled institutions of higher education
Sickle Cell Disease (SCD) Fellowship
$100,000
Pfizer.inc
Private

Application Deadline

Jun 27, 2024

Date Added

May 8, 2024

The Pfizer Sickle Cell Disease (SCD) Fellowship Grant is designed to bolster the number of fellowship programs focused on hematologists who specialize in the treatment of adults with sickle cell disease. This initiative is part of Pfizer Global Medical Grants' broader strategy to support healthcare community-led initiatives that enhance patient outcomes in critical areas of unmet medical need, aligning with Pfizer’s own medical and scientific strategies. The grant aims to enhance the quality of care for sickle cell patients by funding institutions that provide comprehensive training and research opportunities in the field. Specifically, the program supports both established and newly developed fellowship programs that include a robust curriculum in clinical practice, independent research, and education to deepen the scientific understanding of SCD. The fellowship is structured to foster an environment of expert mentorship and significant independent research opportunities. Research activities encouraged under this grant include observational studies and outcomes research that focus on the disease itself, screening tools, and their impact on patient health improvement. Grant funding is set at a maximum of $100,000 for a one-year fellowship, aiming to cover direct costs associated with the fellow’s training and research but explicitly excluding overhead or indirect costs. This financial support underlines Pfizer's commitment to advancing healthcare by investing directly in the development of professionals who are dedicated to improving patient outcomes in the field of sickle cell disease. Key to the grant’s operational framework is compliance with stringent regulatory requirements, including the U.S. Physician Payments Sunshine Act. This act mandates detailed reporting of all transfers of value to ensure transparency and maintain public trust in healthcare practices. The fellowship’s funding structure is designed to be transparent, with specific provisions to prevent any of the funds from benefiting Pfizer's business interests directly or indirectly. Overall, the Pfizer SCD Fellowship embodies a strategic effort to cultivate talent and advance knowledge in a critical area of healthcare, ensuring that the supported programs maintain high standards of integrity and contribute significantly to the field's body of knowledge and patient care practices.

Health
Public and State controlled institutions of higher education
Transthyretin Cardiac Amyloidosis Fellowship Grant
$80,000
Pfizer.inc
Private

Application Deadline

Jun 20, 2024

Date Added

May 8, 2024

The Pfizer Fellowship Grant for Transthyretin Cardiac Amyloidosis is a competitive grant initiative aimed at advancing the professional development of healthcare professionals specializing in the diagnosis and management of ATTR cardiac amyloidosis. This grant is dedicated to enhancing academic and clinical understanding of the disease through research and education. Offered to U.S.-based academic institutions, the program supports fellowship roles for Cardiologists or Heart Failure Advanced Practice Providers, emphasizing a balance of clinical practice, research, and educational outreach. The grant ensures that the supported activities are independent of Pfizer’s commercial interests, focusing on fostering substantial advancements in the field of cardiac health.

Health
Public and State controlled institutions of higher education
Certified Medical Education (CME)/Continuing Education (CE) Grant Funding
Contact for amount
Johnson & Johnson Vision Care, Inc., division of VISTAKON®
Private
Rolling

Application Deadline

Not specified

Date Added

May 8, 2024

This funding opportunity is designed for organizations that provide accredited medical education to healthcare professionals, ensuring their programs meet ethical standards and enhance professional development in specific therapeutic areas.

Health
Public and State controlled institutions of higher education
Hazardous Materials Worker Health and Safety Training (U45 Clinical Trials Not Allowed)
$28,000,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

Jul 8, 2024

Date Added

May 4, 2024

NIEHS invites applications for cooperative agreements to support the development of model programs for the training and education of workers engaged in activities related to hazardous materials and waste generation, removal, containment, transportation and emergency response. This funding opportunity announcement aims to prevent work-related harm through safety and health training. The training programs will transmit skills and knowledge to workers in how best to protect themselves and their communities from exposure to hazardous materials encountered during hazardous waste operations, hazardous materials transportation, environmental restoration of contaminated facilities or chemical emergency response. A variety of sites, such as those involved with chemical waste cleanup and remedial action and transportation-related chemical emergency response, may pose severe health and safety concerns to workers and the surrounding communities. These sites contain many hazardous substances, sometimes unknown, and often a site is uncontrolled. A major goal of the Worker Training Program (WTP) is to support institutional competency-building for the development and delivery of model training and education programs.

Environment
Public and State controlled institutions of higher education
Notice of Intent to Publish a Funding Opportunity Announcement for Building Partnerships and Broadening Perspectives to Advance Ethical, Legal and Social Implications (ELSI) Research (UM1), Clinical Trial Optional
$2,600,000
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Nov 15, 2024

Date Added

Apr 23, 2024

The National Human Genome Research Institute (NHGR) intends to promote a new initiative by publishing a Notice of Funding Opportunity (NOFO) to advance scholarship on the ethical, legal, and social implications (ELSI) of advances in human genetics or genomics, enhance ELSI research teams, build ELSI research capacity, and broaden the ELSI workforce.The intended NOFO will be based on aconceptrecently approved by the National Advisory Council on Human Genome Research and accompanyingdiscussion. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects, and to consult with NIH following release of the intended NOFO to submit responsive applications. The NOFO is expected to be published in summer of 2004 with an expected application due date in fall of 2024. This NOFO will utilize the UM1 activity code (Research Project with Complex Structure, Cooperative Agreement, Clinical Trial Optional). Details of the planned NOFO are provided below.

Health
Public and State controlled institutions of higher education
2024 High-return, Innovative, Transformative (iHIT) Cycle 1
$75,000
Delaware Biotechnology Institute
State

Application Deadline

Jun 1, 2024

Date Added

Apr 22, 2024

iHIT – Ideas – High-return, Innovative, Transformative o Supports ideas in bioscience research that are in the development stage and promise to have a high economic return for innovative and transformative research projects. o This mechanism intends to support applicants to develop novel lines of multidisciplinary research different from their ongoing research. o Up to $75,000 for 1 year.Proposal must be submitted as a single electronic PDF document at the link provided on the CAT website https://cat.dbi.udel.edu. Please note that submission and award processes have changed.

Science and Technology
Public and State controlled institutions of higher education
2024 High-return, Innovative, Transformative (iHIT) Cycle 2
$75,000
Delaware Biotechnology Institute
State

Application Deadline

Dec 1, 2024

Date Added

Apr 22, 2024

This funding opportunity supports innovative bioscience research projects in Delaware that have the potential for significant economic impact, targeting researchers and businesses in the developmental stage.

Science and Technology
Public and State controlled institutions of higher education
FY25 Commuter Assistance Program Grant
$346,604,260
Virginia Department of Education (VDOE)
State

Application Deadline

May 10, 2024

Date Added

Apr 17, 2024

This application is part of the provisions under the 2004 Individuals with Disabilities Education Act (IDEA 2004), its implementing regulations, and the Regulations Governing Special Education Programs for Children with Disabilities in Virginia. It is the formal agreement between local school boards and the Virginia Department of Education (VDOE) to ensure compliance and implementation of federal and state laws concerning special education. The plan outlines the requirements for local educational agencies (LEAs) to receive state and Eligibility is limited to local educational agencies (LEAs), state-operated programs, and the Virginia School for the Deaf and the Blind. Compliance with IDEA and Virginia special education regulations is mandatory.federal funds for educating children with disabilities, necessitating approval from various educational and state bodies. Applications must be submitted electronically via the OMEGA system. Approval from local school boards, the State Special Education Advisory Committee, and respective educational bodies is required.

Education
Public and State controlled institutions of higher education
NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and Craniofacial Research Workforce (F99/K00 Independent Clinical Trial Not Allowed)
Contact for amount
US Department of Health & Human Services (National Institutes of Health)
Federal

Application Deadline

Feb 3, 2025

Date Added

Apr 13, 2024

To support outstanding graduate students from diverse backgrounds, including those from groups underrepresented in biomedical, clinical, behavioral and social sciences, over the transition from predoctoral to postdoctoral research training.. This phased award program will facilitate completion of graduate PhD or dual degree clinician scientist programs (F99) and progression to mentored postdoctoral positions in dental, oral and craniofacial research (K00).

Health
Public and State controlled institutions of higher education
Single Source for the Continuation of the Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed)
Contact for amount
Department of Health and Human Services - National Institutes of Health
Federal

Application Deadline

Jul 22, 2024

Date Added

Apr 6, 2024

This is a non-competitive funding opportunity intended to fund a single award. NCATS is announcing its intent to issue a single source cooperative agreement to Cincinnati Childrens Hospital Medical Center (CCHMC) to support the Data Management and Coordinating Center. The Rare Diseases Clinical Research Network (RDCRN) is intended to advance and improve diagnosis, management, and treatment of numerous, diverse rare diseases through highly collaborative, multi-site, patient-centric, translational, and clinical research with an emphasis on early and timely identification of individuals with rare diseases and clinical trial readiness. The DMCC facilitates and supports the activities of each individual Rare Diseases Clinical Research Consortium (RDCRC) along with trans-network activities that broadly facilitate the advancement of rare disease research via four avenues: administrative support, data management support, clinical research support and patient engagement, and broad dissemination of information. The RDCRCs will continue conducting research conducted under a separate NOFO.

Health
Public and State controlled institutions of higher education
Notice of Intent to Publish a Funding Opportunity Announcement for Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
$375,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

Jun 25, 2024

Date Added

Mar 22, 2024

The National Institutes of Health (NIH) Institutes and Centers (ICs) intend to reissue a Notice of Funding Opportunity (NOFO) to continue the Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) program. The full list of participating ICs will be available in the published NOFO. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. The NOFO is anticipated to be published in Spring 2024 with an expected first application due date in Summer 2024. The NOFO will utilize the R15 activity code. Pertinent details of the planned NOFO are provided below.

Health
Public and State controlled institutions of higher education
Notice of Intent to Publish (NOITP) a Funding Opportunity for Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
$375,000
HHS-NIH11 (National Institutes of Health)
Federal

Application Deadline

Jun 25, 2024

Date Added

Mar 22, 2024

The National Institutes of Health (NIH) Institutes and Centers (ICs) intend to reissue a Notice of Funding Opportunity (NOFO) to continue the Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) program. The full list of participating ICs will be available in the published NOFO. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive applications. The NOFO is anticipated to be published in Spring 2024 with an expected first application due date in Summer 2024. The NOFO will utilize the R15 activity code. Pertinent details of the planned NOFO are provided below.

Health
Public and State controlled institutions of higher education
Notice of Funding Opportunity for the Re-Issue of PAR-21-293 - Clinical and Translational Science Award (UM1 Clinical Trial Optional)
Contact for amount
U.S. Department of Health and Human Services (National Institutes of Health)
Federal

Application Deadline

Sep 14, 2024

Date Added

Mar 22, 2024

The National Center for Advancing Translational Sciences (NCATS) intends to reissue the Notice of Funding Opportunity (NOFO) to solicit applications for the Clinical and Translational Science Award (CTSA) Program hubs that will be part of a national, collaborative consortium focused on bringing more treatments to more patients more quickly through advancing clinical and translational science (CTS). This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The NOFO is expected to be published in Summer 2024 with an expected application due date in January 2025. This NOFO will utilize the UM1 activity code. Details of the planned NOFO are provided below.

Health
Public and State controlled institutions of higher education
2024 Indiana Alcohol Research Center Pilot Project Program
$50,000
Indiana Clinical and Translational Sciences Institute (CTSI)
State

Application Deadline

Sep 3, 2024

Date Added

Mar 21, 2024

The Indiana Alcohol Research Center (IARC) is inviting proposals for pilot projects focusing on alcohol use disorders (AUD). This program aims to support investigators in generating preliminary data that can lead to extramural funding, with special interest in studies on the behavioral, biological, and genetic mechanisms of alcohol preference, binge-level and high-intensity drinking, tolerance, and other AUD-related mechanisms. The program offers up to $50,000 per year for two years, funding up to two projects. Priority is given to early-career investigators or those new to alcohol research, and applicants should be affiliated with the Indiana University system. The application process includes a letter of intent due by August 1, 2024, and a full proposal submission by September 3, 2024. Grant renewed every year. Project during 2 years

Health
Public and State controlled institutions of higher education
2024 Community Health Partnerships (CHeP) Trailblazer Planning Grant
$5,000
Indiana Clinical and Translational Sciences Institute (CTSI)
Private

Application Deadline

Not specified

Date Added

Mar 21, 2024

This funding opportunity supports partnerships between universities and community organizations in Indiana to improve health outcomes and address social determinants of health through collaborative planning activities.

Health
Public and State controlled institutions of higher education
Research Enhancement Grant (REG)
$50,000
Indiana Clinical and Translational Sciences Institute (CTSI)
State

Application Deadline

May 1, 2024

Date Added

Mar 20, 2024

The Research Enhancement Grant (REG) is a program designed to boost research productivity at Indiana University School of Medicine’s statewide Centers for Medical Education, excluding the IUPUI campus. It targets faculty with Assistant, Associate, or Full Professor or Scientist titles, providing up to $50,000 for one-year projects. This initiative encourages scholarly and creative research activities, aiming to equip investigators for successful extramural research support acquisition. The program, funded by the School of Medicine with matching funds from regional campuses, anticipates awarding 2 grants each fiscal year.

Education
Public and State controlled institutions of higher education